Approval · Notice of Compliance 34847 · 2025
PROQUAD: Notice of Compliance 34847
Issued January 20, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34847
- Date
- January 20, 2025
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new route of administration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROQUAD | Not yet assigned | — |
Medicinal ingredients
- VARICELLA VIRUS LIVE ATTENUATED (OKA/MERCK STRAIN) 3.99 PFU per 0.5ML
- RUBELLA VIRUS LIVE ATTENUATED (WISTAR RA 27/3 STRAIN) 3 L10T50 per 0.5ML
- MUMPS VIRUS LIVE ATTENUATED (JERYL LYNN STRAIN) 4.3 L10T50 per 0.5ML
- MEASLES VIRUS LIVE ATTENUATED (EDMONSTON STRAIN) 3 L10T50 per 0.5ML